Search

Author/Creator Samuel, D.

21. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment‐naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II). Issue 7 (4th August 2015)

Authors:
Zeuzem, S.; Flisiak, R.; Vierling, J. M.; Mazur, W.; Mazzella, G.; Thongsawat, S.; Abdurakhmanov, D.; Van Kính, N.; Calistru, P.; Heo, J.; Stanciu, C.; Gould, M.; Makara, M.; Hsu, S.‐J.; Buggisch, P.; Samuel, D.; Mutimer, D.; Nault, B.; Merz, M.; Bao, W.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 42:Issue 7(2015)
Page Start:
829
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study. Issue 12 (17th April 2018)

Authors:
Anty, R.; Favre, G.; Coilly, A.; Rossignol, E.; Houssel‐Debry, P.; Duvoux, C.; De Ledinghen, V.; Di Martino, V.; Leroy, V.; Radenne, S.; Kamar, N.; Canva, V.; D'Alteroche, L.; Durand, F.; Dumortier, J.; Lebray, P.; Besch, C.; Tran, A.; Canivet, C. M.; Botta‐Fridlund, D.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 12(2018)
Page Start:
1682
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗